vs

Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and RAYONIER INC (RYN). Click either name above to swap in a different company.

PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $117.5M, roughly 1.4× RAYONIER INC). RAYONIER INC runs the higher net margin — 22.1% vs -82.0%, a 104.0% gap on every dollar of revenue. On growth, PTC THERAPEUTICS, INC. posted the faster year-over-year revenue change (-22.7% vs -81.9%). Over the past eight quarters, RAYONIER INC's revenue compounded faster (1.7% CAGR vs -11.5%).

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

Rayonier Inc., headquartered in Wildlight, Florida is a timberland real estate investment trust ("REIT") with assets located in softwood timber growing regions in the United States and New Zealand. Its core business segments are timber and real estate.

PTCT vs RYN — Head-to-Head

Bigger by revenue
PTCT
PTCT
1.4× larger
PTCT
$164.7M
$117.5M
RYN
Growing faster (revenue YoY)
PTCT
PTCT
+59.2% gap
PTCT
-22.7%
-81.9%
RYN
Higher net margin
RYN
RYN
104.0% more per $
RYN
22.1%
-82.0%
PTCT
Faster 2-yr revenue CAGR
RYN
RYN
Annualised
RYN
1.7%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PTCT
PTCT
RYN
RYN
Revenue
$164.7M
$117.5M
Net Profit
$-135.0M
$25.9M
Gross Margin
41.9%
Operating Margin
-43.3%
23.0%
Net Margin
-82.0%
22.1%
Revenue YoY
-22.7%
-81.9%
Net Profit YoY
-104.8%
-92.1%
EPS (diluted)
$-1.63
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PTCT
PTCT
RYN
RYN
Q4 25
$164.7M
$117.5M
Q3 25
$211.0M
$177.5M
Q2 25
$178.9M
$106.5M
Q1 25
$1.2B
$82.9M
Q4 24
$213.2M
$650.5M
Q3 24
$196.8M
$124.1M
Q2 24
$186.7M
$99.6M
Q1 24
$210.1M
$113.7M
Net Profit
PTCT
PTCT
RYN
RYN
Q4 25
$-135.0M
$25.9M
Q3 25
$15.9M
$43.2M
Q2 25
$-64.8M
$408.7M
Q1 25
$866.6M
$-3.4M
Q4 24
$-65.9M
$327.1M
Q3 24
$-106.7M
$28.8M
Q2 24
$-99.2M
$1.9M
Q1 24
$-91.6M
$1.4M
Gross Margin
PTCT
PTCT
RYN
RYN
Q4 25
41.9%
Q3 25
32.9%
Q2 25
29.7%
Q1 25
21.7%
Q4 24
53.8%
Q3 24
30.4%
Q2 24
25.4%
Q1 24
24.3%
Operating Margin
PTCT
PTCT
RYN
RYN
Q4 25
-43.3%
23.0%
Q3 25
1.4%
23.5%
Q2 25
-19.5%
13.7%
Q1 25
82.5%
0.1%
Q4 24
-76.2%
47.7%
Q3 24
-27.7%
15.2%
Q2 24
-21.5%
4.6%
Q1 24
-21.6%
7.6%
Net Margin
PTCT
PTCT
RYN
RYN
Q4 25
-82.0%
22.1%
Q3 25
7.5%
24.3%
Q2 25
-36.3%
383.6%
Q1 25
73.7%
-4.1%
Q4 24
-30.9%
45.1%
Q3 24
-54.2%
23.2%
Q2 24
-53.1%
1.9%
Q1 24
-43.6%
1.2%
EPS (diluted)
PTCT
PTCT
RYN
RYN
Q4 25
$-1.63
$0.14
Q3 25
$0.20
$0.28
Q2 25
$-0.83
$2.63
Q1 25
$10.04
$-0.02
Q4 24
$-0.85
$2.18
Q3 24
$-1.39
$0.19
Q2 24
$-1.29
$0.01
Q1 24
$-1.20
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PTCT
PTCT
RYN
RYN
Cash + ST InvestmentsLiquidity on hand
$1.9B
$842.9M
Total DebtLower is stronger
$845.3M
Stockholders' EquityBook value
$-205.3M
$2.2B
Total Assets
$2.9B
$3.4B
Debt / EquityLower = less leverage
0.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PTCT
PTCT
RYN
RYN
Q4 25
$1.9B
$842.9M
Q3 25
$1.7B
$919.6M
Q2 25
$2.0B
$892.3M
Q1 25
$2.0B
$216.2M
Q4 24
$1.1B
$303.1M
Q3 24
$1.0B
$51.9M
Q2 24
$1.1B
$120.2M
Q1 24
$884.8M
$142.1M
Total Debt
PTCT
PTCT
RYN
RYN
Q4 25
$845.3M
Q3 25
$845.1M
Q2 25
$844.9M
Q1 25
$1.0B
Q4 24
$1.0B
Q3 24
$1.3B
Q2 24
$1.4B
Q1 24
$1.4B
Stockholders' Equity
PTCT
PTCT
RYN
RYN
Q4 25
$-205.3M
$2.2B
Q3 25
$-155.8M
$2.3B
Q2 25
$-206.5M
$2.3B
Q1 25
$-185.8M
$1.9B
Q4 24
$-1.1B
$1.8B
Q3 24
$-1.1B
$1.8B
Q2 24
$-980.2M
$1.8B
Q1 24
$-893.9M
$1.8B
Total Assets
PTCT
PTCT
RYN
RYN
Q4 25
$2.9B
$3.4B
Q3 25
$2.6B
$3.5B
Q2 25
$2.6B
$3.5B
Q1 25
$2.7B
$3.4B
Q4 24
$1.7B
$3.5B
Q3 24
$1.8B
$3.5B
Q2 24
$1.9B
$3.5B
Q1 24
$1.8B
$3.6B
Debt / Equity
PTCT
PTCT
RYN
RYN
Q4 25
0.38×
Q3 25
0.37×
Q2 25
0.37×
Q1 25
0.55×
Q4 24
0.59×
Q3 24
0.72×
Q2 24
0.75×
Q1 24
0.74×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PTCT
PTCT
RYN
RYN
Operating Cash FlowLast quarter
$-34.3M
$256.7M
Free Cash FlowOCF − Capex
$-36.6M
FCF MarginFCF / Revenue
-22.3%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
9.91×
TTM Free Cash FlowTrailing 4 quarters
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PTCT
PTCT
RYN
RYN
Q4 25
$-34.3M
$256.7M
Q3 25
$-66.3M
$116.2M
Q2 25
$-58.3M
$61.0M
Q1 25
$870.1M
$27.7M
Q4 24
$-30.0M
$261.6M
Q3 24
$-77.0M
$66.2M
Q2 24
$-71.5M
$55.3M
Q1 24
$70.8M
$52.3M
Free Cash Flow
PTCT
PTCT
RYN
RYN
Q4 25
$-36.6M
Q3 25
$-69.7M
$99.9M
Q2 25
$-59.6M
Q1 25
$868.4M
Q4 24
$-33.8M
Q3 24
$-77.5M
$42.2M
Q2 24
$-78.8M
Q1 24
$61.2M
FCF Margin
PTCT
PTCT
RYN
RYN
Q4 25
-22.3%
Q3 25
-33.1%
56.3%
Q2 25
-33.3%
Q1 25
73.8%
Q4 24
-15.8%
Q3 24
-39.4%
34.0%
Q2 24
-42.2%
Q1 24
29.1%
Capex Intensity
PTCT
PTCT
RYN
RYN
Q4 25
1.4%
Q3 25
1.6%
9.2%
Q2 25
0.7%
Q1 25
0.1%
Q4 24
1.8%
Q3 24
0.3%
19.3%
Q2 24
4.0%
Q1 24
4.6%
Cash Conversion
PTCT
PTCT
RYN
RYN
Q4 25
9.91×
Q3 25
-4.17×
2.69×
Q2 25
0.15×
Q1 25
1.00×
Q4 24
0.80×
Q3 24
2.30×
Q2 24
29.07×
Q1 24
38.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PTCT
PTCT

Segment breakdown not available.

RYN
RYN

Real Estate Segment$42.3M36%
Pacific Northwest Timber Segment$19.8M17%
Stumpage Pay As Cut$19.3M16%
Improved Development$14.8M13%
Nontimber$13.2M11%
License Revenue Primarily From Hunting$5.3M4%
Land Based Solutions$2.9M2%

Related Comparisons